FDA clears CAD between Fischer Imaging and R2 Technology

TriMed Staff | | Health Imaging | Diagnostic Imaging
The FDA has given the go-ahead to Fischer Imaging Corp. and R2 Technology Inc. to integrate their respective technologies.

 The ruling allows Fischer Imaging to integrate its SenoScan digital mammography system with R2's computer-aided detection (CAD) technology. In addition, R2 Technology's ImageChecker DM analog system -- which received FDA clearance in September -- also will support CAD analysis of digital images acquired on the SenoScan system.

 The ImageChecker DM System will be distributed directly by Fischer and R2.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.